<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270094" xml:lang="en" article-type="case-study"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40070929</article-id><article-id pub-id-type="pmc">PMC11894263</article-id>
<article-id pub-id-type="doi">10.1002/deo2.70094</article-id><article-id pub-id-type="publisher-id">DEO270094</article-id><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Revealing autoimmune gastritis: Polypoid nodule scar development after endoscopic submucosal dissection for early gastric cancer</article-title><alt-title alt-title-type="left-running-head">MASUDA <sc>et&#x000a0;al</sc>.</alt-title></title-group><contrib-group><contrib id="deo270094-cr-0001" contrib-type="author" corresp="yes"><name><surname>Masuda</surname><given-names>Naoya</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0000-3127-8054</contrib-id><xref rid="deo270094-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="deo270094-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>masuda.naoya.k9@f.gifu-u.ac.jp</email></address></contrib><contrib id="deo270094-cr-0002" contrib-type="author"><name><surname>Yamazaki</surname><given-names>Kenji</given-names></name><xref rid="deo270094-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270094-cr-0003" contrib-type="author"><name><surname>Maruyama</surname><given-names>Yasuhiko</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0269-7799</contrib-id><xref rid="deo270094-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo270094-cr-0004" contrib-type="author"><name><surname>Kushima</surname><given-names>Ryoji</given-names></name><xref rid="deo270094-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="deo270094-cr-0005" contrib-type="author"><name><surname>Hasebe</surname><given-names>Nae</given-names></name><xref rid="deo270094-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270094-cr-0006" contrib-type="author"><name><surname>Ozawa</surname><given-names>Noritaka</given-names></name><xref rid="deo270094-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270094-cr-0007" contrib-type="author"><name><surname>Shimizu</surname><given-names>Shogo</given-names></name><xref rid="deo270094-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270094-cr-0008" contrib-type="author"><name><surname>Shimizu</surname><given-names>Masahito</given-names></name><xref rid="deo270094-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="deo270094-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>Gifu Prefectural General Medical Center</institution>
<city>Gifu</city>
<country country="JP">Japan</country>
</aff><aff id="deo270094-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>Gifu University School of Medicine</institution>
<city>Gifu</city>
<country country="JP">Japan</country>
</aff><aff id="deo270094-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<institution>Fujieda Municipal General Hospital</institution>
<city>Shizuoka</city>
<country country="JP">Japan</country>
</aff><aff id="deo270094-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Pathology</named-content>
<institution>Shiga University of Medical Science</institution>
<city>Shiga</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Naoya Masuda, Department of Gastroenterology, Gifu University School of Medicine, 1&#x02010;1 Yanagido, Gifu 501&#x02010;1194, Japan.<break/> Email: <email>masuda.naoya.k9@f.gifu-u.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="18">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70094</elocation-id><history>
<date date-type="rev-recd"><day>24</day><month>2</month><year>2025</year></date>
<date date-type="received"><day>06</day><month>1</month><year>2025</year></date>
<date date-type="accepted"><day>28</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70094.pdf"/><abstract><title>Abstract</title><p>Endoscopic submucosal dissection (ESD), the standard treatment for early gastric cancer, typically results in homogeneous flat scars. However, in some cases, polypoid nodule scars (PNS) may develop, complicating the cancer recurrence assessment. This case report describes a 60&#x02010;year&#x02010;old man with a history of <italic toggle="yes">Helicobacter pylori</italic> infection who underwent two ESD procedures: first for early antral gastric cancer and then for gastric body adenoma. Subsequently, an erythematous protruding lesion developed at the antral ESD scar site. Lesion biopsy revealed regenerative and hyperplastic tissue growth, consistent with PNS. Despite <italic toggle="yes">H. pylori</italic> eradication therapy and discontinuation of potassium&#x02010;competitive acid blockers and H<sub>2</sub>&#x02010;receptor antagonists, the lesion continued to enlarge. PNS growth may be caused by excessive mucosal regeneration and enhanced antral peristalsis, suggesting that hypergastrinemia, which may enhance these effects, may be an underlying cause. Further, elevated serum gastrin levels, decreased pepsinogen levels, the presence of antiparietal cell antibodies, and consistent pathological findings confirmed autoimmune gastritis (AIG).</p><p>This case highlights the diagnostic challenges of AIG, especially in cases of active or previous <italic toggle="yes">H. pylori</italic> infection because typical endoscopic features may be obscured. Persistent PNS after ESD warrants the consideration of excessive mucosal regeneration and enhanced peristalsis, with AIG as a potential cause because of its association with hypergastrinemia. To our knowledge, this is the first case report describing a potential link between AIG and PNS.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270094-kwd-0001">autoimmune gastritis</kwd><kwd id="deo270094-kwd-0002">endoscopic submucosal dissection</kwd><kwd id="deo270094-kwd-0003">gastrin</kwd><kwd id="deo270094-kwd-0004"><italic toggle="yes">Helicobacter pylori</italic></kwd><kwd id="deo270094-kwd-0005">polypoid nodule scar</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="0"/><page-count count="5"/><word-count count="2444"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:07.04.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo270094-sec-0010"><title>INTRODUCTION</title><p>Endoscopic submucosal dissection (ESD) is the preferred treatment for early gastric cancer with no or low risk of lymph node metastasis,<xref rid="deo270094-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> after which postoperative scars typically appear homogeneous and whitish, often with converging folds. Arantes et&#x000a0;al. reported that post&#x02010;ESD endoscopy can reveal irregular scarring and large protruding nodules, particularly in the gastric antrum, termed polypoid nodule scars (PNS),<xref rid="deo270094-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> which can complicate the evaluation of post&#x02010;ESD cancer recurrence.</p><p>Autoimmune gastritis (AIG) is characterized by hypergastrinemia and the autoimmune destruction of parietal cells, leading to the production of autoantibodies including antiparietal cell antibodies (APCA), against proton pumps (H+/K+ ATPase). Various triggers for AIG diagnosis have been reported, including endoscopic screening, macrocytic anemia, iron deficiency anemia, thyroid disease, gastric cancer, and close examination of gastric neuroendocrine tumors.<xref rid="deo270094-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo270094-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="deo270094-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Despite new Japan Gastroenterological Endoscopy Society criteria,<xref rid="deo270094-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> diagnosing AIG is challenging with active or previous <italic toggle="yes">Helicobacter pylori</italic> infection, and efforts are ongoing to establish reliable diagnostic methods for such cases.</p><p>In this report, we describe the case of a 60&#x02010;year&#x02010;old man with a history of <italic toggle="yes">H. pylori</italic> infection who underwent ESD and subsequently developed persistent PNS. Despite the lack of typical endoscopic features of AIG, the progressive nature of PNS led us to consider excessive mucosal regeneration and enhanced antral peristaltic activity, suggesting hypergastrinemia as a potential cause, ultimately leading to a diagnosis of AIG.</p></sec><sec id="deo270094-sec-0020"><title>CASE REPORT</title><p>A 60&#x02010;year&#x02010;old man with a history of hypertension, type 2 diabetes, and mild gastroesophageal reflux disease was referred to our hospital for further evaluation after undergoing an upper gastrointestinal endoscopy during a routine physical examination. Endoscopy suggested <italic toggle="yes">H. pylori</italic> infection and early cancer of the gastric antrum.</p><p>After a thorough endoscopic examination at our hospital, early gastric cancer in the posterior wall of the gastric antrum was confirmed. ESD was performed to remove cancerous lesions (Figure&#x000a0;<xref rid="deo270094-fig-0001" ref-type="fig">1a,b</xref>). The resected specimen was pathologically diagnosed as a well&#x02010;differentiated adenocarcinoma with a resection diameter of 35 &#x000d7; 28&#x000a0;mm, negative margins, and intramucosal depth. ORISE ProKnife 2.0 (Boston Scientific Co.) and a hyaluronic acid solution were used for local injection. The patient was treated postoperatively with 20&#x000a0;mg of vonoprazan, a potassium&#x02010;competitive acid blocker (P&#x02010;CAB), and recovered uneventfully.</p><fig position="float" fig-type="FIGURE" id="deo270094-fig-0001"><label>FIGURE 1</label><caption><p>(a) Type 0&#x02013;IIc early gastric cancer is approximately 10&#x000a0;mm in diameter, erythematous, and located on the posterior wall of the gastric antrum. The background mucosa shows atrophic changes and intestinal metaplasia. (b) The resection site after endoscopic submucosal dissection. (c) An intestinal adenoma, approximately 5&#x000a0;mm in diameter, is observed on the posterior wall of the gastric body. Background mucosal atrophy is also observed. (d) The resection site after endoscopic submucosal dissection.</p></caption><graphic xlink:href="DEO2-5-e70094-g002" position="anchor" id="jats-graphic-1"/></fig><p>Five months later, a second ESD was performed to remove the adenoma found on the posterior wall of the gastric body during the initial endoscopy (Figure&#x000a0;<xref rid="deo270094-fig-0001" ref-type="fig">1c,d</xref>), which was pathologically diagnosed as an intestinal&#x02010;type adenoma measuring 25 &#x000d7; 25&#x000a0;mm with negative margins. The same device and local injection technique were used, and the patient again received postoperative vonoprazan with a favorable recovery. After endoscopic treatment, <italic toggle="yes">H. pylori</italic> eradication therapy was performed. Successful eradication was confirmed by a urea breath test 10 months after the first ESD.</p><p>Two months after the first ESD of the gastric antrum, a gradually enlarging, erythematous, and irregularly protruding lesion with white moss&#x02010;like adhesions emerged at the scar site (Figure&#x000a0;<xref rid="deo270094-fig-0002" ref-type="fig">2a</xref>). Lesion biopsy revealed regenerative and hyperplastic tissue without local cancer recurrence, consistent with PNS. Suspecting a possible adverse effect of P&#x02010;CAB, prescribed for the treatment of post&#x02010;ESD ulcers, we unavoidably switched medication to H<sub>2</sub>&#x02010;receptor antagonists (H2RA) for mild heartburn. However, the lesion continued to grow (Figure&#x000a0;<xref rid="deo270094-fig-0002" ref-type="fig">2b</xref>). Despite successful <italic toggle="yes">H. pylori</italic> eradication, the protruding lesion in the gastric antrum persisted and enlarged (Figure&#x000a0;<xref rid="deo270094-fig-0002" ref-type="fig">2c</xref>). However, the PNS was not observed in the post&#x02010;ESD gastric body ulcer area (Figure&#x000a0;<xref rid="deo270094-fig-0002" ref-type="fig">2d</xref>).</p><fig position="float" fig-type="FIGURE" id="deo270094-fig-0002"><label>FIGURE 2</label><caption><p>(a) Two months after the first endoscopic submucosal dissection (ESD) of the gastric antrum, the polypoid nodule scar (PNS) has gradually enlarged to approximately 20&#x000a0;mm in diameter. (b) Five months after the first ESD of the gastric antrum, the PNS has continued to enlarge, reaching approximately 30&#x000a0;mm in diameter and exhibiting an increasingly irregular shape, despite switching from vonoprazan to H<sub>2</sub>&#x02010;receptor antagonist therapy. (c) Ten months after the first ESD of the gastric antrum, the PNS has continued to enlarge, reaching approximately 35&#x000a0;mm in diameter with a rough lobulated surface, despite successful <italic toggle="yes">H. pylori</italic> eradication. (d) Two years after the second ESD of the gastric body, no PNS is observed in the post&#x02010;ESD ulcer area of the gastric body.</p></caption><graphic xlink:href="DEO2-5-e70094-g004" position="anchor" id="jats-graphic-3"/></fig><p>Excessive mucosal regeneration and increased peristaltic antral activity have been reported as potential causes of PNS.<xref rid="deo270094-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> In this case, despite the eradication of <italic toggle="yes">H. pylori</italic> and adjustments to medications, potentially contributing to excessive mucosal regeneration,<xref rid="deo270094-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270094-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> the PNS continued to enlarge. Hypergastrinemia has also been implicated as a contributing factor in these processes.<xref rid="deo270094-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo270094-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Therefore, biopsies of the gastric antrum and body and serum tests were conducted to evaluate AIG as a differential cause of hypergastrinemia.</p><p>Pathological examination of biopsies from the gastric body (Figure&#x000a0;<xref rid="deo270094-fig-0003" ref-type="fig">3a&#x02013;c</xref>) and antrum (Figure&#x000a0;<xref rid="deo270094-fig-0003" ref-type="fig">3d</xref>) revealed findings consistent with an advanced florid stage of AIG.<xref rid="deo270094-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Blood tests showed elevated APCA titers (160 &#x000d7;; normal value&#x000a0;&#x0003c;10&#x000d7;) and an increased serum gastrin level (425.9&#x000a0;pmol/L; normal range 11.9&#x02013;46.9&#x000a0;pmol/L) in the absence of P&#x02010;CAB or H2RA. Furthermore, the pepsinogen I level and I/II ratio decreased. Endoscopic, histological, and serological findings confirmed the diagnosis of AIG.<xref rid="deo270094-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Furthermore, the histopathological findings from the second gastric body ESD resected specimen were consistent with those of an advanced florid stage of AIG complicated by <italic toggle="yes">H. pylori</italic> infection (Figure <xref rid="deo270094-supinfo-0001" ref-type="">S1a,b</xref>).</p><fig position="float" fig-type="FIGURE" id="deo270094-fig-0003"><label>FIGURE 3</label><caption><p>(a) A biopsy of the gastric body shows degeneration and loss of parietal cells; Decreased glandular density due to the progression of pseudopyloric gland metaplasia (mucous neck cell proliferation), foveolar elongation, and intense lymphocytic infiltration, mainly into tissues deeper than the isthmus, can be seen. Intestinal metaplasia is also observed (hematoxylin and eosin [HE] staining, &#x000d7; 40). (b) Magnified view of the area is indicated by the red frame in Figure&#x000a0;<xref rid="deo270094-fig-0003" ref-type="fig">3a</xref> (HE staining, &#x000d7; 80). (c) Chromogranin A staining shows linear, tubular, and nodular hyperplasia of enterochromaffin&#x02010;like cells. (d) A biopsy of the greater curvature of the gastric antrum shows focal intestinal metaplasia. However, the degree of atrophy in the pyloric glands is less severe than in the oxyntic glands of the gastric body, with scarce lymphocytic infiltration. G&#x02010;cell hyperplasia is also observed (HE staining, &#x000d7; 40).</p></caption><graphic xlink:href="DEO2-5-e70094-g003" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="deo270094-sec-0030"><title>DISCUSSION</title><p>A multicenter study reported that PNS occurred in the distal stomach in 1.2% of post&#x02010;ESD cases.<xref rid="deo270094-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Excessive mucosal regeneration, peristaltic stimulation, bile reflux, <italic toggle="yes">H. pylori</italic> infection, gastric mucosal hyperplasia induced by H2RAs, proton pump inhibitors, and P&#x02010;CABs are possible mechanisms underlying PNS development.<xref rid="deo270094-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270094-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="deo270094-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> However, to our knowledge, no studies have investigated the relationship between serum gastrin levels and the development of PNS or a potential association between PNS and AIG.</p><p>As AIG progresses, severe atrophy of the gastric body occurs, leading to achlorhydria and hypergastrinemia through a negative feedback mechanism. Gastrin promotes gastric mucosal proliferation<xref rid="deo270094-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> and stimulates gastric peristalsis.<xref rid="deo270094-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Hypergastrinemia&#x02010;induced excessive mucosal regeneration and increased peristaltic activity are consistent with the pathogenesis of PNS.<xref rid="deo270094-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="deo270094-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> These findings suggest that excessive gastrin signaling contributes to the development of PNS by overstimulating mucosal repair mechanisms and enhancing gastric antral motility.</p><p>In this case, despite the eradication of <italic toggle="yes">H. pylori</italic> infection and adjustments to medications, the PNS continued to enlarge. Endoscopic and pathological examinations of the antrum after <italic toggle="yes">H. pylori</italic> eradication revealed minimal inflammation and bile acid reflux was of negligible impact. The involvement of hypergastrinemia was subsequently confirmed as causing excessive mucosal regeneration and increased peristalsis, and AIG was diagnosed through additional blood tests and pathological examinations.</p><p>In this case, ESD was performed at different anatomical locations, providing crucial insights into the mechanisms underlying PNS development. After <italic toggle="yes">H. pylori</italic> eradication, inflammation improved in the antrum but persisted in the gastric body owing to AIG. Under these conditions, the PNS continued to enlarge exclusively in the antral region but was not observed in the body, suggesting that PNS development is more strongly influenced by location&#x02010;specific factors in the antrum, such as strong peristalsis, than by background mucosal inflammation.</p><p>Upon reviewing the pre&#x02010;ESD endoscopic images in this case, AIG was not initially suspected due to extensive intestinal metaplasia and mucosal erythema in the gastric antrum (Figure&#x000a0;<xref rid="deo270094-fig-0004" ref-type="fig">4a</xref>), obscuring the characteristic &#x0201c;inverse atrophy&#x0201d; pattern of AIG. However, the gastric body exhibited extensive, marked atrophic changes, suggesting a possible concurrence of AIG and <italic toggle="yes">H. pylori</italic> infection (Figure&#x000a0;<xref rid="deo270094-fig-0004" ref-type="fig">4b</xref>). Re&#x02010;evaluation of endoscopic imaging after <italic toggle="yes">H. pylori</italic> eradication showed glossy mucosa with residual intestinal metaplasia in the gastric antrum (Figure&#x000a0;<xref rid="deo270094-fig-0004" ref-type="fig">4c</xref>) with persistent, significant gastric body atrophy (Figure&#x000a0;<xref rid="deo270094-fig-0004" ref-type="fig">4d</xref>). Although <italic toggle="yes">H. pylori</italic> infection skewed gastric antrum imaging, pronounced gastric body atrophy compared to gastric antrum atrophy should have been considered characteristic of AIG.</p><fig position="float" fig-type="FIGURE" id="deo270094-fig-0004"><label>FIGURE 4</label><caption><p>(a) Endoscopic images before <italic toggle="yes">H. pylori</italic> eradication show diffuse erythema and intestinal metaplasia in the gastric antrum which is associated with <italic toggle="yes">H. pylori</italic> infection. (b) Marked atrophy is also observed in the gastric body. (c) Endoscopic images after <italic toggle="yes">H. pylori</italic> eradication show that although intestinal metaplasia remains, no atrophic changes are observed in the gastric antrum because the inflammation has resolved, and the mucosa appears glossy. (d) In contrast, the gastric body exhibits marked atrophic changes.</p></caption><graphic xlink:href="DEO2-5-e70094-g001" position="anchor" id="jats-graphic-7"/></fig><p>PNS may recur after resection but may not require intervention in the absence of malignancy or symptomatic anemia. ESD combined with localized steroid injections has been proposed as a potential therapeutic option.<xref rid="deo270094-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Furthermore, PNS may be prevented by shortening the duration of proton pump inhibitors/PCABs or H2RA therapy and suturing the ulcer base to avoid exposure.</p><p>This case demonstrates that diagnosing the concurrence of active or previous <italic toggle="yes">H. pylori</italic> infection and AIG remains challenging. Clinicians should consider underlying hypergastrinemia in patients who develop PNS after ESD. AIG is an important differential diagnosis, potentially causing elevated gastrin levels. Although the association between PNS and AIG should be further studied, hypergastrinemia may be a clinically relevant risk factor for PNS in patients with AIG. To our knowledge, this is the first case report describing a potential link between AIG and PNS, offering a novel perspective for AIG diagnosis.</p></sec><sec sec-type="COI-statement" id="deo270094-sec-0050"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo270094-sec-0060"><title>ETHICS STATEMENT</title><p>Institutional Reviewer Board approval and Trial Registration are not applicable (N/A).</p></sec><sec id="deo270094-sec-0070"><title>PATIENT CONSENT STATEMENT</title><p>Informed consent was obtained from the patients.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo270094-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="deo270094-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>FIGURE S1</bold> (a) Reexamination of the resected specimen obtained from the second endoscopic submucosal dissection of the gastric body shows degeneration and loss of parietal and chief cells, pseudopyloric gland metaplasia (mucous neck cell proliferation), foveolar elongation, and intense lymphocytic infiltration, primarily in tissues deeper than the isthmus. Focal intestinal metaplasia is observed (hematoxylin and eosin staining, &#x000d7; 40). (b) Chromogranin A staining shows linear, tubular, and nodular hyperplasia of enterochromaffin&#x02010;like cells.</p></caption><media xlink:href="DEO2-5-e70094-s001.tif"/></supplementary-material><supplementary-material id="deo270094-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>FIGURE S2</bold> The clinical course of the patient.</p></caption><media xlink:href="DEO2-5-e70094-s002.tif"/></supplementary-material></sec></body><back><ack id="deo270094-sec-0040"><title>ACKNOWLEDGMENTS</title><p>We are grateful to the staff of the Pathonet Corporation for their support of the pathology laboratory. We would like to thank Editage (<ext-link xlink:href="http://www.editage.jp" ext-link-type="uri">www.editage.jp</ext-link>) for the English language editing.</p></ack><ref-list id="deo270094-bibl-0001"><title>REFERENCES</title><ref id="deo270094-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270094-cite-0001">
<string-name>
<surname>Ono</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujishiro</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. 2nd ed</article-title>. <source>Dig Endosc</source>
<year>2021</year>; <volume>33</volume>: <fpage>4</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">33107115</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270094-cite-0002">
<string-name>
<surname>Arantes</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Uedo</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Pedrosa</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Tomita</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Clinical relevance of aberrant polypoid nodule scar after endoscopic submucosal dissection</article-title>. <source>World J Gastrointest Endosc</source>
<year>2016</year>; <volume>8</volume>: <fpage>628</fpage>&#x02013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">27668074</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270094-cite-0003">
<string-name>
<surname>Toh</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>van Driel</surname>
<given-names>IR</given-names>
</string-name>, <string-name>
<surname>Gleeson</surname>
<given-names>PA</given-names>
</string-name>. <article-title>Pernicious anemia</article-title>. <source>N Engl J Med</source>
<year>1997</year>; <volume>337</volume>: <fpage>1441</fpage>&#x02013;<lpage>1448</lpage>.<pub-id pub-id-type="pmid">9358143</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270094-cite-0004">
<string-name>
<surname>Kitamura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Muguruma</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Clinicopathological characteristics of early gastric cancer associated with autoimmune gastritis</article-title>. <source>JGH Open</source>
<year>2021</year>; <volume>5</volume>: <fpage>1210</fpage>&#x02013;<lpage>1215</lpage>.<pub-id pub-id-type="pmid">34622010</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270094-cite-0005">
<string-name>
<surname>Sato</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hashimoto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>
<given-names>KI</given-names>
</string-name>, <string-name>
<surname>Tkeuchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Terai</surname>
<given-names>S</given-names>
</string-name>. <article-title>Management of gastric and duodenal neuroendocrine tumors</article-title>. <source>World J Gastroenterol</source>
<year>2016</year>; <volume>22</volume>: <fpage>6817</fpage>&#x02013;<lpage>6828</lpage>.<pub-id pub-id-type="pmid">27570419</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270094-cite-0006">
<string-name>
<surname>Kamada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Furuta</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan</article-title>. <source>J Gastroenterol</source>
<year>2023</year>; <volume>58</volume>: <fpage>185</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">36855000</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270094-cite-0007">
<string-name>
<surname>Arantes</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Uedo</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Morita</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Polypoid nodule scar after gastric endoscopic submucosal dissection: Results from a multicenter study</article-title>. <source>Endosc Int Open</source>
<year>2018</year>; <volume>6</volume>: <fpage>1198</fpage>&#x02013;<lpage>1203</lpage>.</mixed-citation></ref><ref id="deo270094-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270094-cite-0008">
<string-name>
<surname>Bhandari</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bakke</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>J</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Connective tissue growth factor is activated by gastrin and involved in gastrin&#x02010;induced migration and invasion</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2016</year>; <volume>475</volume>: <fpage>119</fpage>&#x02013;<lpage>124</lpage>.<pub-id pub-id-type="pmid">27179776</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270094-cite-0009">
<string-name>
<surname>Schuurkes</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Charbon</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Pentagastrin stimulates tonic and phasic contractile activity of the canine stomach</article-title>. <source>Arch Int Pharmacodyn Ther</source>
<year>1979</year>; <volume>239</volume>: <fpage>128</fpage>&#x02013;<lpage>1437</lpage>.<pub-id pub-id-type="pmid">485709</pub-id>
</mixed-citation></ref><ref id="deo270094-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270094-cite-0010">
<string-name>
<surname>Tachikawa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chiba</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ashikari</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Local steroid injection prevented recurrent formation of hyperplastic polyp at the site of endoscopic submucosal dissection of gastric adenoma</article-title>. <source>Gastroenterol Endosc</source>
<year>2020</year>; <volume>62</volume>: <fpage>476</fpage>&#x02013;<lpage>83</lpage>.</mixed-citation></ref></ref-list></back></article>